01.09.2011 | Short review
Long-term results in children with standard risk acute lymphoblastic leukaemia treated with 5.0 g/m2 versus 3.0 g/m2 methotrexate i.v. according to the modified ALL-BFM 90 protocol. The report of Polish paediatric Leukemia/lymphoma study group
Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2011
Einloggen, um Zugang zu erhaltenAnzeige